Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Porphyria Cutanea Tarda Presenting as Erythema-multiforme Like Lesions.

Parajuli N, Jha HK, Jonkman MF.

J Nepal Health Res Counc. 2019 Apr 28;17(1):119-121. doi: 10.33314/jnhrc.1132.

PMID:
31110391
2.

Keratinocyte footprint assay discriminates anti-laminin-332 pemphigoid from all other forms of pemphigoid diseases.

Giurdanella F, Nijenhuis AM, Diercks GFH, Jonkman MF, Pas HH.

Br J Dermatol. 2019 May 15. doi: 10.1111/bjd.18129. [Epub ahead of print]

PMID:
31090065
3.

Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis.

Lamberts A, Meijer JM, Pas HH, Diercks GFH, Horváth B, Jonkman MF.

J Am Acad Dermatol. 2019 Apr 19. pii: S0190-9622(19)30620-6. doi: 10.1016/j.jaad.2019.04.029. [Epub ahead of print]

PMID:
31009674
4.

Incomplete systemic lupus erythematosus - what remains after application of ACR and SLICC criteria?

Lambers WM, Westra J, Jonkman MF, Bootsma H, de Leeuw K.

Arthritis Care Res (Hoboken). 2019 Apr 1. doi: 10.1002/acr.23894. [Epub ahead of print]

PMID:
30932354
5.

Impact of Painful Wound Care in Epidermolysis Bullosa During Childhood: An Interview Study with Adult Patients and Parents.

Mauritz P, Jonkman MF, Visser SS, Finkenauer C, Duipmans JC, Hagedoorn M.

Acta Derm Venereol. 2019 Mar 21. doi: 10.2340/00015555-3179. [Epub ahead of print]

6.

Epidermolysis Bullosa Acquisita: The 2019 Update.

Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K.

Front Med (Lausanne). 2019 Jan 10;5:362. doi: 10.3389/fmed.2018.00362. eCollection 2018. Review.

7.

Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.

Meijer JM, Diercks GFH, de Lang EWG, Pas HH, Jonkman MF.

JAMA Dermatol. 2019 Jan 9. doi: 10.1001/jamadermatol.2018.4390. [Epub ahead of print]

PMID:
30624575
8.

Detection of u-serrated patterns in direct immunofluorescence images of autoimmune bullous diseases by inhibition-augmented COSFIRE filters.

Shi C, Meijer JM, Guo J, Azzopardi G, Diercksr GFH, Schmidt E, Zillikens D, Jonkman MF, Petkov N.

Int J Med Inform. 2019 Feb;122:27-36. doi: 10.1016/j.ijmedinf.2018.11.007. Epub 2018 Nov 28.

PMID:
30623781
9.

[Pruritus in elderly: diagnosis and treatment].

Leus AJG, Meijer JM, Zuidema SU, Jonkman MF.

Ned Tijdschr Geneeskd. 2018 Dec 20;163. pii: D2350. Dutch.

PMID:
30604601
10.

KLHL24: Beyond Skin Fragility.

Bolling MC, Jonkman MF.

J Invest Dermatol. 2019 Jan;139(1):22-24. doi: 10.1016/j.jid.2018.08.010.

PMID:
30579426
11.

Allogeneic Haematopoietic Cell Transplantation for Epidermolysis Bullosa: the Dutch Experience.

Gostyńska KB, Yenamandra VK, Lindemans C, Duipmans J, Gostyński A, Jonkman MF, Boelens JJ.

Acta Derm Venereol. 2019 Mar 1;99(3):347-348. doi: 10.2340/00015555-3097. No abstract available.

12.

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.

Lee J, Werth VP, Hall RP 3rd, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS.

Front Med (Lausanne). 2018 Nov 8;5:306. doi: 10.3389/fmed.2018.00306. eCollection 2018.

13.

Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.

Schräder NHB, Duipmans JC, Molenbuur B, Wolff AP, Jonkman MF.

Br J Dermatol. 2019 Apr;180(4):922-924. doi: 10.1111/bjd.17341. Epub 2018 Nov 14.

PMID:
30347109
14.

Unmet Needs in Pemphigoid Diseases: An International Survey Amongst Patients, Clinicians and Researchers.

Lamberts A, Yale M, Grando SA, Horváth B, Zillikens D, Jonkman MF.

Acta Derm Venereol. 2019 Feb 1;99(2):224-225. doi: 10.2340/00015555-3052. No abstract available.

15.

Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria.

de Groot HJ, Jonkman MF, Pas HH, Diercks GFH.

Acta Derm Venereol. 2019 Jan 1;99(1):26-32. doi: 10.2340/00015555-3021.

16.

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH.

PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

17.

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaas9668. doi: 10.1126/scitranslmed.aas9668.

PMID:
30135250
18.

Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.

Bremer J, Kramer D, Eichhorn DS, Gostyński A, Diercks GFH, Jonkman MF, van den Akker PC, Pasmooij AMG.

Exp Dermatol. 2018 Jul 17. doi: 10.1111/exd.13744. [Epub ahead of print]

PMID:
30019435
19.

A rare case with prominent features of both discoid lupus erythematosus and pemphigus foliaceus.

Bilgic Temel A, Ergün E, Poot AM, Bassorgun CI, Akman-Karakaş A, Uzun S, Alpsoy E, Pas HH, Jonkman MF.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e5-e7. doi: 10.1111/jdv.15099. Epub 2018 Jun 13. No abstract available.

PMID:
29858874
20.

Cardiomyopathy in patients with epidermolysis bullosa simplex with mutations in KLHL24.

Yenamandra VK, van den Akker PC, Lemmink HH, Jan SZ, Diercks GFH, Vermeer M, van den Berg MP, van der Meer P, Pasmooij AMG, Sinke RJ, Jonkman MF, Bolling MC.

Br J Dermatol. 2018 Nov;179(5):1181-1183. doi: 10.1111/bjd.16797. Epub 2018 Aug 14. No abstract available.

PMID:
29779254
21.

Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative.

Giurdanella F, Nijenhuis AM, Diercks GFH, Jonkman MF, Pas HH.

Front Immunol. 2018 Apr 24;9:839. doi: 10.3389/fimmu.2018.00839. eCollection 2018.

22.

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

Lamberts A, Euverman HI, Terra JB, Jonkman MF, Horváth B.

Front Immunol. 2018 Feb 19;9:248. doi: 10.3389/fimmu.2018.00248. eCollection 2018.

23.

Generalized Ichthyotic Peeling Skin Syndrome due to FLG2 Mutations.

Bolling MC, Jan SZ, Pasmooij AMG, Lemmink HH, Franke LH, Yenamandra VK, Sinke RJ, van den Akker PC, Jonkman MF.

J Invest Dermatol. 2018 Aug;138(8):1881-1884. doi: 10.1016/j.jid.2018.01.038. Epub 2018 Mar 2. No abstract available.

PMID:
29505760
24.

Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Samavedam UK, Mitschker N, Kasprick A, Bieber K, Schmidt E, Laskay T, Recke A, Goletz S, Vidarsson G, Schulze FS, Armbrust M, Schulze Dieckhoff K, Pas HH, Jonkman MF, Kalies K, Zillikens D, Gupta Y, Ibrahim SM, Ludwig RJ.

Front Immunol. 2018 Feb 15;9:249. doi: 10.3389/fimmu.2018.00249. eCollection 2018.

25.

A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.

van den Akker PC, Pasmooij AMG, Joenje H, Hofstra RMW, Te Meerman GJ, Jonkman MF.

PLoS One. 2018 Feb 22;13(2):e0192994. doi: 10.1371/journal.pone.0192994. eCollection 2018.

26.

High-efficiency RNA-based reprogramming of human primary fibroblasts.

Kogut I, McCarthy SM, Pavlova M, Astling DP, Chen X, Jakimenko A, Jones KL, Getahun A, Cambier JC, Pasmooij AMG, Jonkman MF, Roop DR, Bilousova G.

Nat Commun. 2018 Feb 21;9(1):745. doi: 10.1038/s41467-018-03190-3.

27.

Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins.

Romero Pastrana F, Neef J, Koedijk DGAM, de Graaf D, Duipmans J, Jonkman MF, Engelmann S, van Dijl JM, Buist G.

Sci Rep. 2018 Feb 19;8(1):3234. doi: 10.1038/s41598-018-21724-z.

28.

Image Gallery: Paraneoplastic pemphigus and follicular dendritic cell sarcoma.

Jonkman MF, Pas HH.

Br J Dermatol. 2018 Feb;178(2):e146. doi: 10.1111/bjd.16146. No abstract available.

PMID:
29441554
29.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

30.

From the wound to the bench: exoproteome interplay between wound-colonizing Staphylococcus aureus strains and co-existing bacteria.

García-Pérez AN, de Jong A, Junker S, Becher D, Chlebowicz MA, Duipmans JC, Jonkman MF, van Dijl JM.

Virulence. 2018 Jan 1;9(1):363-378. doi: 10.1080/21505594.2017.1395129.

31.

International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.

Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, Iranzo P, Daneshpazhooh M, Terra J, Bauer J, Fairley J, Hall R, Hertl M, Lehman JS, Marinovic B, Patsatsi A, Zillikens D; International Bullous Diseases Group, Werth V, Woodley DT, Murrell DF.

Br J Dermatol. 2018 Jul;179(1):30-41. doi: 10.1111/bjd.16138. Epub 2018 May 8. Review.

PMID:
29165796
32.

Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases.

Meijer JM, Atefi I, Diercks GFH, Vorobyev A, Zuiderveen J, Meijer HJ, Pas HH, Zillikens D, Schmidt E, Jonkman MF.

J Am Acad Dermatol. 2018 Apr;78(4):754-759.e6. doi: 10.1016/j.jaad.2017.11.029. Epub 2017 Nov 16.

PMID:
29154993
33.

Nonbullous pemphigoid: A systematic review.

Lamberts A, Meijer JM, Jonkman MF.

J Am Acad Dermatol. 2018 May;78(5):989-995.e2. doi: 10.1016/j.jaad.2017.10.035. Epub 2017 Nov 1. Review.

PMID:
29102490
34.

Pain Quality Assessment Scale for Epidermolysis Bullosa.

Schräder NHB, Yuen WY, Jonkman MF.

Acta Derm Venereol. 2018 Mar 13;98(3):346-349. doi: 10.2340/00015555-2827.

35.

Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus.

Spindler V, Eming R, Schmidt E, Amagai M, Grando S, Jonkman MF, Kowalczyk AP, Müller EJ, Payne AS, Pincelli C, Sinha AA, Sprecher E, Zillikens D, Hertl M, Waschke J.

J Invest Dermatol. 2018 Jan;138(1):32-37. doi: 10.1016/j.jid.2017.06.022. Epub 2017 Oct 14. Review.

36.

HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus.

de Sena Nogueira Maehara L, De-Souza-Santana FC, Porro AM, Marcos EVC, Ura S, Nolte IM, Pas HH, Jonkman MF, Tomimori J.

Br J Dermatol. 2018 Mar;178(3):e212-e214. doi: 10.1111/bjd.16022. Epub 2018 Jan 16. No abstract available.

PMID:
28977698
37.

Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'.

Jonkman MF, Meijer JM, Diercks GFH, Pas HH.

Br J Dermatol. 2018 Feb;178(2):573. doi: 10.1111/bjd.16023. Epub 2018 Jan 9. No abstract available.

PMID:
28977674
38.

Ectopic hidradenitis suppurativa on the dorsal foot of a road maker.

Rondags A, Diercks GF, Werker PMN, Jonkman MF, Horváth B.

JAAD Case Rep. 2017 Sep 1;3(5):429-431. doi: 10.1016/j.jdcr.2017.06.002. eCollection 2017 Sep. No abstract available.

39.

Nuclear Proteins and Apoptotic Bodies Are Found in the Lupus Band of Patients with Cutaneous Lupus Erythematosus.

Koopman K, Romeijn TR, de Leeuw K, Jonkman MF, Pas HH, Diercks GFH.

J Invest Dermatol. 2017 Dec;137(12):2652-2654. doi: 10.1016/j.jid.2017.08.006. Epub 2017 Aug 31. No abstract available.

40.

Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus.

Mindorf S, Dettmann IM, Krüger S, Fuhrmann T, Rentzsch K, Karl I, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, Sárdy M, Bangert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman MF, Stöcker W, Schmidt E; International Autoimmune Bullous Diseases Study Group.

Exp Dermatol. 2017 Dec;26(12):1267-1270. doi: 10.1111/exd.13409. Epub 2017 Oct 29.

PMID:
28815795
41.

Intraepidermal neutrophilic dermatosis type of IgA pemphigus with circulating linear IgA disease antibodies associated with ulcerative colitis.

Papakonstantinou E, Kapp A, Jonkman MF, Raap U.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e10-e11. doi: 10.1111/jdv.14436. Epub 2017 Jul 16. No abstract available.

PMID:
28653439
42.

Epidermolysis Bullosa Simplex Caused by Distal Truncation of BPAG1-e: An Intermediate Generalized Phenotype with Prurigo Papules.

Turcan I, Pasmooij AMG, Gostyński A, van den Akker PC, Lemmink HH, Diercks GFH, Pas HH, Sinke RJ, Jonkman MF.

J Invest Dermatol. 2017 Oct;137(10):2227-2230. doi: 10.1016/j.jid.2017.04.041. Epub 2017 May 27. No abstract available.

43.

Immunofluorescence of Autoimmune Bullous Diseases.

Diercks GF, Pas HH, Jonkman MF.

Surg Pathol Clin. 2017 Jun;10(2):505-512. doi: 10.1016/j.path.2017.01.011. Epub 2017 Mar 30. Review.

PMID:
28477893
44.

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines JF, Belheouane M, Bernard P, Borradori L, Caproni M, Di Zenzo G, Grando S, Harman K, Jonkman MF, Koga H, Ludwig RJ, Kowalczyk AP, Müller EJ, Nishie W, Pas H, Payne AS, Sadik CD, Seppänen A, Setterfield J, Shimizu H, Sinha AA, Sprecher E, Sticherling M, Ujiie H, Zillikens D, Hertl M, Waschke J.

J Invest Dermatol. 2017 Jun;137(6):1199-1203. doi: 10.1016/j.jid.2017.01.028. Epub 2017 Apr 5. Review.

45.

Particle Bombardment of Ex Vivo Skin to Deliver DNA and Express Proteins.

Sokol E, Nijenhuis M, Sjollema KA, Jonkman MF, Pas HH, Giepmans BNG.

Methods Mol Biol. 2017;1559:107-118. doi: 10.1007/978-1-4939-6786-5_9.

PMID:
28063041
46.

Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Hirose M, Kasprick A, Beltsiou F, Dieckhoff Schulze K, Schulze FS, Samavedam UK, Hundt JE, Pas HH, Jonkman MF, Schmidt E, Kalies K, Zillikens D, Ludwig RJ, Bieber K.

Mol Med. 2017 Feb;22:918-926. doi: 10.2119/molmed.2015.00206. Epub 2016 Dec 20.

47.

Carriers with functional null mutations in LAMA3 have localized enamel abnormalities due to haploinsufficiency.

Gostyńska KB, Yan Yuen W, Pasmooij AM, Stellingsma C, Pas HH, Lemmink H, Jonkman MF.

Eur J Hum Genet. 2016 Jan;25(1):94-99. doi: 10.1038/ejhg.2016.136. Epub 2016 Nov 9.

48.

PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.

Koga H, Recke A, Vidarsson G, Pas HH, Jonkman MF, Hashimoto T, Kasprick A, Ghorbanalipoor S, Tenor H, Zillikens D, Ludwig RJ.

J Invest Dermatol. 2016 Nov;136(11):2211-2220. doi: 10.1016/j.jid.2016.06.619. Epub 2016 Jul 5.

49.

A PLEC Isoform Identified in Skin, Muscle, and Heart.

Gostyńska KB, Lemmink H, Bremer J, Pas HH, Nijenhuis M, van den Akker PC, Sinke RJ, Jonkman MF, Pasmooij AMG.

J Invest Dermatol. 2017 Feb;137(2):518-522. doi: 10.1016/j.jid.2016.09.032. Epub 2016 Oct 18. No abstract available.

50.

Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa.

Bremer J, Bornert O, Nyström A, Gostynski A, Jonkman MF, Aartsma-Rus A, van den Akker PC, Pasmooij AM.

Mol Ther Nucleic Acids. 2016 Oct 18;5(10):e379. doi: 10.1038/mtna.2016.87.

Supplemental Content

Loading ...
Support Center